Biomorphological and related technical aspects affecting phage activity for inhaled application
S. Wienhold (Berlin, Germany), M. Brack (Berlin, Germany), W. Groenewald (Berlin, Germany), G. Nouailles (Berlin, Germany), I. Korf (Braunschweig, Germany), M. Rohde (Braunschweig, Germany), C. Seitz (Braunschweig, Germany), A. Dannheim (Braunschweig, Germany), S. Wienecke (Braunschweig, Germany), H. Ziehr (Braunschweig, Germany), C. Rohde (Braunschweig, Germany), M. Witzenrath (Berlin, Germany)
Source: Virtual Congress 2020 – Translational science in respiratory infections
Session: Translational science in respiratory infections
Session type: E-poster session
Number: 2326
Disease area: Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Wienhold (Berlin, Germany), M. Brack (Berlin, Germany), W. Groenewald (Berlin, Germany), G. Nouailles (Berlin, Germany), I. Korf (Braunschweig, Germany), M. Rohde (Braunschweig, Germany), C. Seitz (Braunschweig, Germany), A. Dannheim (Braunschweig, Germany), S. Wienecke (Braunschweig, Germany), H. Ziehr (Braunschweig, Germany), C. Rohde (Braunschweig, Germany), M. Witzenrath (Berlin, Germany). Biomorphological and related technical aspects affecting phage activity for inhaled application. 2326
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Technical aspects of physical activity monitoring Source: International Congress 2015 – PG13 Monitoring physical activity Year: 2015
When biology meets behaviour: can medication adherence mask the contribution of pharmacogenetic effects in asthma? Source: Eur Respir J, 58 (3) 2100304; 10.1183/13993003.00304-2021 Year: 2021
SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting ß2 -agonist use in asthma Source: Eur Respir J, 55 (2) 1901858; 10.1183/13993003.01858-2019 Year: 2020
Is the clinical application of specific airway resistance in young children limited by inter-centre differences? Reported on behalf of the asthma UK ‘growing lungs‘ initiative Source: Annual Congress 2009 - Paediatric lung function, imaging and methodology in health and disease Year: 2009
Usefulness of a new JACS questionnaire in assessing the influence of inhalation guidance on asthma control level; comparison of 4 different devices of ICS/LABA Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018
The role of inhaled antibiotics in bronchial infection Source: Eur Respir Monogr 2013; 60: 120-126 Year: 2013
Optimal adherence with inhaled corticosteroids is related to better health status Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015
Minimising the environmental impact of inhaled therapies: problems with policy on low carbon inhalers Source: Eur Respir J, 55 (2) 2000048; 10.1183/13993003.00048-2020 Year: 2020
Minimising the environmental impact of inhaled therapies: problems with policy on low carbon inhalers Source: Eur Respir J, 55 (5) 2001122; 10.1183/13993003.01122-2020 Year: 2020
Evaluating the effects of asthma therapy on childhood growth: principles of study design Source: Eur Respir J 2002; 19: 1167-1178 Year: 2002
Comparitive efficiency of different approaches to basic therapy of bronchial asthma of moderate form Source: Eur Respir J 2006; 28: Suppl. 50, 441s Year: 2006
The influence of genetic and phenotypic factors over the ability to perform different physical exercises in a short programme of pulmonary rehabilitation Source: Annual Congress 2009 - Are outcome measures useful to predict success in rehabilitation and the care of patients with chronic respiratory disease Year: 2009
Is there evidence showing that real-life aspects (comorbid conditions, inhaler technique, and lifetstyle factors) influence asthma management? Source: International Congress 2014 – The evolving role of real-life research in respiratory medicine Year: 2014
Expanding role of aerosols: systemic drug delivery, gene therapy and vaccination Source: Annual Congress 2007 - ISAM - Expanding role of aerosols: systemic drug delivery, gene therapy and vaccination Year: 2007
Change of inhalation device: impact on asthma control and compliance in general practice. SYSTER survey Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II Year: 2008
Knowledge and skills for inhaled drugs before and after a rehabilitation program in COPD: a real life study Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? Year: 2018
Evaluating the effects of asthma therapy on childhood growth: what can be learnt from the published literature? Source: Eur Respir J 2002; 19: 1179-1193 Year: 2002
A critical evaluation of the relevance of different asthma phenotypes for clinical practice Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium Year: 2008
The challenge of increasing physical activity in the presence of asthma: a qualitative study of teachers‘ experiences and views Source: Annual Congress 2009 - Quality of treatment in primary respiratory care Year: 2009
Daily pattern of ß2-agonists: understanding real-life use of rescue medication Source: International Congress 2017 – Asthma management Year: 2017